Stock listing
NASDAQ:LJPC La Jolla Pharmaceutical Co Stock
Follow La Jolla Pharmaceutical Co into a list and get an email when it puts out news.
Last close · NASDAQ:LJPC
$6.22 USD
Close on Aug 22, 2022 · No longer trades
- Lowest – highest close
- $2.42 – $43.90 USDSince Jan 29, 2014 · lowest Nov 26, 2019 · highest Sep 8, 2015
Delisted NASDAQ:LJPC no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:LJPC
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
La Jolla Pharmaceutical Co on 6ix
- Decks
- 13 decks · latest Dec 29, 2017
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (December 2017) | Investor deck | 13 slides | Dec 29, 2017 |
| Investor Presentation (April 2017) | Investor deck | 36 slides | Apr 11, 2017 |
| Technical Presentation (February 2017) | Technical | 16 slides | Feb 28, 2017 |
| Investor Presentation (September 2016) | Investor deck | 34 slides | Sep 19, 2016 |
| Technical Presentation (September 2016) | Technical | 9 slides | Sep 8, 2016 |
| Investor Presentation (January 2016) | Investor deck | 33 slides | Jan 11, 2016 |
| Investor Presentation (July 2015) | Investor deck | 17 slides | Jul 27, 2015 |
| Investor Presentation (July 2015) | Investor deck | 31 slides | Jul 27, 2015 |
| Investor Presentation (October 2014) | Investor deck | 38 slides | Oct 14, 2014 |
| Investor Presentation (July 2014) | Investor deck | 37 slides | Jul 22, 2014 |
All 13 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (May 2013) | Investor deck | 40 slides | May 16, 2013 |
| Investor Presentation (February 2013) | Investor deck | 51 slides | Feb 4, 2013 |
| RetailInvestorConferences.com Live Webcast (July 2012) | Conference | 27 slides | Jul 13, 2012 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Craig Johnson Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Nov 7, 2024); Heron Therapeutics, Inc. (Lead Independent Director · Since at least Jan 10, 2014); PURE Bioscience (Chief Financial Officer · Aug 1, 2011 – Aug 1, 2011 · Past); DMK Pharmaceuticals Corporation (Director · Feb 10, 2011 – Oct 16, 2013 · Past); Ardea Biosciences Inc (Director · Jan 3, 2011 – Jun 19, 2012 · Past) | Director · Oct 14, 2013 – Aug 22, 2022 · Past |
| Kevin Tang Other companies: Aurinia Pharmaceuticals Inc (Chief Executive Officer, Director · Since at least Sep 12, 2024); Jounce Therapeutics Inc (Director · May 3, 2023 – May 3, 2023 · Past); Heron Therapeutics, Inc. (Director · Dec 22, 2015 – Dec 31, 2019 · Past) | Director · Aug 19, 2015 – Aug 22, 2022 · Past |
| David Ramsay Other companies: Halozyme Therapeutics, Inc. (President, Drug Delivery · Since at least Mar 23, 2026); Savara, Inc. (Director · Since at least Jun 19, 2019) | Director · Oct 8, 2019 – Aug 22, 2022 · Past |
| Robert Rosen Other companies: ImmunityBio, Inc. (Director · Jul 27, 2015 – Jul 27, 2015 · Past); Heron Therapeutics, Inc. (President, Director · May 1, 2013 – Dec 15, 2018 · Past) | Director · Jul 7, 2014 – Aug 22, 2022 · Past |
| Saiid Zarrabian Other companies: TuHURA Biosciences, Inc. (Head of Strategic Partnerships, Director · Jul 7, 2017 – Dec 6, 2021 · Past); Penwest Pharmaceuticals Co (Director · Jun 30, 2010 – Sep 20, 2010 · Past) | Director · Jan 19, 2012 – May 14, 2015 · Past |
| Larry G Edwards Other companies: Innoviva, Inc. (CEO of La Jolla Pharmaceutical · Aug 22, 2022 – Aug 22, 2022 · Past) | Chief Executive Officer, Director · Dec 10, 2020 – Aug 22, 2022 · Past |
| Michael Hearne Other companies: Aurinia Pharmaceuticals Inc (Chief Financial Officer · Since at least Mar 23, 2026) | Officer · Jun 1, 2020 – Aug 22, 2022 · Past |
Log in to ask 6ix AI your own questions about La Jolla Pharmaceutical Co.